Score the ultimate productivity suite while a one-and-done purchase is just $40, an 81% discount that's sure to go quickly.
The TikTok video's instructions are simple and promise to easily solve a problem you have - but it's a ruse. Here's what happens next.
AI and hyperscale demand are breaking the energy model. The next generation of data centers will be built on power strategies that bypass the grid entirely Data center growth has always been fast.
Palestinian Ambassador to India, Abdullah Abu Shawesh lauded India by saying that it is a key player when it comes to political issues. Palestinians flag outside the Royal Courts of Justice.
We're a month into the 2025 NFL season, and anxiety is setting in for many teams. The Ravens have arguably hit rock bottom, losing games and star players to injury at alarming rates. The Vikings don't ...
Court hears cases on Trump-era executive power, transgender rights, and more; rejects Ghislaine Maxwell appeal as new term begins. Trump complains about ‘really weird’ Time magazine photo Hundreds of ...
Policing data hosted in Microsoft’s hyperscale cloud infrastructure could be processed in more than 100 countries, but the tech giant is obfuscating this information from its customers, Computer ...
A drone photo taken on Aug 8, 2025 shows a demonstration project for integrated photovoltaic and energy storage in Dongying city, East China's Shandong province. [Photo/Xinhua] China's electricity ...
Oct 1 (Reuters) - Dataiku, an artificial intelligence data analytics startup, has hired investment banks to push ahead with an initial public offering, according to people familiar with the matter.
US colo developer Digital Realty has signed a deal with Current Hydro LLC for 500GWh of hydropower from three projects on the Ohio River. Under the terms of the agreement, Digital Realty has agreed to ...
TL;DR: If you're looking for a powerful productivity suite without recurring subscription fees, Microsoft Office 2021 is available for just $39 for a limited time, an incredible deal. This offer ...
H1 2026: Finalize formulation and manufacture test product. H1 2026 Initial Phase 1 pharmacokinetic clinical cross-over study. "Our pipeline is focused on research in therapeutic areas where we can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results